Becton, Dickinson and Company

811 articles with Becton, Dickinson and Company

• BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis

  3/16/2023

  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD Vaginal Panel on the BD COR™ System.

• BD to Present at Barclays Global Healthcare Conference

  3/1/2023

  BD, a leading global medical technology company, announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time.

• BD to Present at Cowen 43rd Annual Healthcare Conference

  2/21/2023

  BD, a leading global medical technology company, announced that it will present at the Cowen 43rd Annual Healthcare Conference on Monday, March 6, 2023 at 9:50 am Eastern Time.

• BD Named as One of America's Best Large Employers

  2/15/2023

  BD, a leading global medical technology company, announced that the company has been named to America's Best Large Employers List 2023 by Forbes, furthering its progress against the company's environmental, social and governance strategy.

• BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery

  2/3/2023

  BD (Becton, Dickinson and Company) today announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines including immunology, genetic disease research, and cancer and chronic disease research.

• BD Reports First Quarter Fiscal 2023 Financial Results

  2/2/2023

  BD, a leading global medical technology company, announced results for its first quarter of fiscal 2023, which ended December 31, 2022.

• BD Publishes 2022 Cybersecurity Annual Report

  1/25/2023

  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company's ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities.

• BD Board Declares Dividend - Jan 24, 2023

  1/24/2023

  The Board of Directors of BD has declared a quarterly dividend of $0.91 per common share, payable on March 31, 2023 to holders of record on March 10, 2023.

• BD Introduces Fully Automated Robotic Track System for Microbiology Labs

  1/11/2023

  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a new, robotic track system for the BD Kiestra™ microbiology laboratory solution that automates lab specimen processing, which may help to reduce manual labor and wait time for results.

• Michelle Quinn Named Acting General Counsel for BD

  1/6/2023

  BD, a leading global medical technology company, announced that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat Khichi, who has informed the company of his intent to depart BD for a new opportunity, effective Feb. 3, 2023.

• BD Announces Webcast of Annual Meeting of Shareholders - Jan 06, 2023

  1/6/2023

  BD, a leading global medical technology company, announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 24, 2023, at 1 p.m..

• New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer

  1/5/2023

  BD, a leading global medical technology company, released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022, among 872 U.S. women ages 18 to 64 years old, that indicate a significant gap in women's knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.

• BD to Announce Financial Results for its First Quarter of Fiscal 2023

  1/5/2023

  BD, a leading global medical technology company, announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023.

• BD to Present at the 41st Annual J.P. Morgan Healthcare Conference

  12/20/2022

  BD, a leading global medical technology company, announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 12:45 pm Eastern Time.

• BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report

  12/8/2022

  BD (Becton, Dickinson and Company) today announced the release of its second annual Global Inclusion, Diversity and Equity Report for fiscal year 2022.

• BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

  11/10/2022

  BD, a leading global medical technology company, announced results for its fourth quarter and full year of fiscal 2022, which ended September 30, 2022.

• BD Board Increases Dividend for 51st Consecutive Year

  11/10/2022

  The Board of Directors of BD has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022.

• BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy

  10/18/2022

  BD (Becton, Dickinson and Company) today announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.

• BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs

  10/18/2022

  BD, a leading global medical technology company, and Biocorp, a medical device and delivery systems manufacturer based in France, announced that they have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics.

• BD Recognized Among World's Best Employers by Forbes

  10/11/2022

  BD, a leading global medical technology company, was named to Forbes' 2022 list of the World's Best Employers.